Curapath’s on the Move: Upcoming Conferences & Events 2025

Curapath is gearing up for a busy season of innovation, networking, and collaboration. Over the next few months, our team will be present at some of the world’s leading biotech and pharmaceutical conferences, connecting with partners, sharing insights, and showcasing our latest advances in drug delivery technologies. 

Here’s where you’ll find us this fall and winter:

  • BIOPC 2025, Lyon, France from 22–23 September
  • BioSpain 2025, Barcelona, Spain from 7–9 October
  • CPHI Frankfurt 2025, Frankfurt, Germany from 28–30 October 
  • PODD Conference, Boston, USA from 27–28 October
  • International mRNA Health Conference, Berlin, Germany from 12–14 November
  • TIDES Europe 2025, Basel, Switzerland from 11–13 November
  • COMPAMED 2025, Düsseldorf, Germany from 17–18 November
  • Biofit 2025, Strasbourg, France from 2–3 December

Each event is a chance to exchange ideas with global leaders in biotech, pharma, and health innovation, that’s why we want to share how Curapath is advancing cutting-edge delivery systems for tomorrow’s therapies. 

Stay tuned for more details on where to meet our team, the sessions we’ll be attending, and the breakthroughs we’ll be highlighting at each event.

The Latest from Curapath
Nanothera Summit 2025 brings science and innovation to Valencia

NanoThera Summit 2025: An event that consolidates Valencia as a key hub for innovation in nanotherapies and advanced Therapies Valencia, September 2025 The inaugural edition of...

Curapath Strengthens PEG-Free Delivery Platform Through Exclusive Agreement with Calusa Bio

Curapath has entered into an exclusive license agreement with Calusa Bio, LLC, further strengthening its PEG alternative toolbox with a novel and differentiated technology. This strategic...

Curapath and Cayman Chemical Partner to Expand Access to PEG-Free Shielding Lipids for Advanced LNP Formulations

VALENCIA, SPAIN, SEPTEMBER 2, 2025 At Curapath, our mission has always been to push the boundaries of non-viral drug delivery. Today, we are proud to announce...